60 Degrees Pharma Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$1.70

+0.01 (+0.59%)

As of Jun 25, 5:41 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +56.5% upside

Low Target $2.13

Average Target $2.66

High Target $3.16

Current Price $1.70

Current
$1.70

Target
$2.66

$2.13 $2.66 avg $3.16

Scenario Analysis

Bear Case

$2.13

25.3%

Low target

Base Case

$2.66

+56.5%

Avg target

Bull Case

$3.16

+85.9%

High target

Risk/Reward

3.4x

Highly favorable

Price in Context

52-Week High

$10.77

-84.2% from high

52-Week Low

$1.22

+39.3% from low

Target vs 52W High

$2.66

-75.3% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	79%	$1,330.33	+18.3%
RDY Dr. Reddy's Laboratories	Sell	44	50%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	68%	$299.55	+22.2%
MRK Merck & Co. Inc.	Buy	36	69%	$159.27	+27.7%
PFE Pfizer Inc.	Hold	36	42%	$33.90	+42.3%
BMY Bristol-Myers Squibb Co	Hold	36	39%	$174.50	+217.3%
ZTS Zoetis Inc	Buy	24	58%	$209.87	+170.3%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-33.2%